Answer
Dexmedetomidine hydrochloride is excreted in human milk, with levels below detection by 24 hours after stopping treatment; infant risk cannot be excluded, so breastfeeding or treatment must be discontinued after weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Dexdor 100 micrograms/ml concentrate for solution for infusionOrion Pharma (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked